AggreSure ß-Amyloid (1-40), human – 0.25 mg

Overview

AggreSure ß-Amyloid (1-40), human peptide is essential for your research into Alzheimer’s Disease (AD), the most prevalent neurodegenerative disorder affecting the elderly. This peptide has undergone a rigorous pretreatment process and has been tested for aggregation using the SensoLyte® ThT Aβ40 Aggregation kit (Cat# AS-72213). With a net quantity of 0.25 mg, the integrity of this peptide ensures reliable results in your studies of senile plaques and neurofibrillary tangles, common characteristics of AD found in the cerebral cortex and hippocampus.

Key Features

• Pretested for aggregation, ensuring high-quality results
• Weight of 0.25 mg, suitable for various applications
• Used in conjunction with the SensoLyte® ThT Aβ40 Aggregation kit
• Ideal for research related to Alzheimer’s Disease
• Available for purchase at competitive pricing

Specifications

FAQ

How is AggreSure ß-Amyloid (1-40) used in research?

This peptide is primarily used in research focused on Alzheimer’s Disease and can help in the study of amyloid aggregation, contributing to a better understanding of disease mechanisms.

Is the aggregation of this peptide guaranteed?

Yes, the AggreSure ß-Amyloid (1-40) peptide is pretreated and tested for aggregation, which ensures its reliability for research applications.

Where can I find other peptides for my research?

You can explore our extensive collection of peptides, including the PKG Substrate and Autocamtide-2to support your research needs.

Don’t miss the opportunity to enhance your research with the AggreSure ß-Amyloid (1-40), human peptide. Shop now to improve your understanding of Alzheimer’s Disease and related neurodegenerative processes.

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled

Browse more in Peptides.